Overview

Workflow Optimization During Pulse Field Ablation for Atrial Fibrillation

Status:
NOT_YET_RECRUITING
Trial end date:
2030-12-31
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of intravenous lidocaine in reducing diaphragmatic contraction and suppressing the cough reflex during pulsed field ablation procedures.
Phase:
PHASE4
Details
Lead Sponsor:
National Taiwan University Hospital
Collaborator:
Johnson & Johnson
Treatments:
Lidocaine
Sodium Chloride